Résultats à court terme d’un traitement de la lèpre par le 4,4’-diisoamyloxythiocarbanilide

Abstract
A preliminary clinical study, in a small number of patients and over a limited period of time, shows that 4,4[image]-diisoamyloxythiocarbanilide (Isoxyl), a non-toxic substance, is definitely active in lepromatous forms of leprosy.

This publication has 1 reference indexed in Scilit: